Nguyen-minh-an B. Tran

Ho Chi Minh City, SG, Viet Nam

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Correction: Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders.

Correction: Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders.

Journal: Molecular diagnosis & therapy

Published: October 09, 2023

Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders.

Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders.

Journal: Molecular diagnosis & therapy

Published: April 30, 2023

α-Glucosidase inhibitory activities of flavonoid derivatives isolated from Bouea macrophylla: in vitro and in silico studies.

α-Glucosidase inhibitory activities of flavonoid derivatives isolated from Bouea macrophylla: in vitro and in silico studies.

Journal: RSC advances

Published: January 31, 2023

α-Glucosidase Inhibitory and Antimicrobial Benzoylphloroglucinols from Garcinia schomburgakiana Fruits: In Vitro and In Silico Studies.

α-Glucosidase Inhibitory and Antimicrobial Benzoylphloroglucinols from Garcinia schomburgakiana Fruits: In Vitro and In Silico Studies.

Journal: Molecules (Basel, Switzerland)

Published: March 21, 2022

In silico and in vitro studies on the anti-cancer activity of artemetin, vitexicarpin and penduletin compounds from Vitex negundo.

In silico and in vitro studies on the anti-cancer activity of artemetin, vitexicarpin and penduletin compounds from Vitex negundo.

Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Published: February 24, 2022

Microneedles enable the development of skin-targeted vaccines against coronaviruses and influenza viruses.

Microneedles enable the development of skin-targeted vaccines against coronaviruses and influenza viruses.

Journal: Pharmaceutical development and technology

Published: November 22, 2021

Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders.

Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders.

Journal: Neurochemical research

Published: September 25, 2021

Alpha-glucosidase inhibitors from Nervilia concolor, Tecoma stans, and Bouea macrophylla.

Alpha-glucosidase inhibitors from Nervilia concolor, Tecoma stans, and Bouea macrophylla.

Journal: Saudi journal of biological sciences

Published: July 25, 2021

Nanotechnology-based drug delivery for central nervous system disorders.

Nanotechnology-based drug delivery for central nervous system disorders.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 02, 2021

Identification of Highly Potent α-Glucosidase Inhibitors from Artocarpus integer and Molecular Docking Studies.

Identification of Highly Potent α-Glucosidase Inhibitors from Artocarpus integer and Molecular Docking Studies.

Journal: Chemistry & biodiversity

Published: June 24, 2021

Nervione, a new benzofuran derivative from Nervilia concolor.

Nervione, a new benzofuran derivative from Nervilia concolor.

Journal: Natural product research

Published: May 10, 2021

Flavones from Combretum quadrangulare Growing in Vietnam and Their Alpha-Glucosidase Inhibitory Activity.

Flavones from Combretum quadrangulare Growing in Vietnam and Their Alpha-Glucosidase Inhibitory Activity.

Journal: Molecules (Basel, Switzerland)

Published: April 11, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026